| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |